March/April 2022 Newsletter |
|
In This Issue:
- President's Message
- Board of Director's Update
- Public Policy Update
- R & E Foundation Update
- Preceptor Development: How to Enhance Preceptor Skills to Ensure Student Success
- Pharmacist Continuing Education Articles
- Nonsteroidal Mineralcorticoid Receptor Antagonists in Diabetic Kidney Disease
- Review of Calcitonin Gene-Related Peptide (CGRP) Inhibitors for Migraine Treatment
- Tenecteplase Compared to Alteplase for Acute Ischemic Strokes
- Featured Clinical Topics:
- Opioid Use Disorder: Identification and Management in the Acute Setting
- Magnesium for the Treatment of Postoperative Pain
- Lumateperone for Treatment of Schizophrenia
- Pandemic-Induced Anxiety Leads to Increased Cannabis Use in Pregnant Women
- The Effects of Marijuana on Adolescent Development
- Affiliate Chapter News and Events
- Upcoming Newsletter Info
|
|
By Christina Stafford, PharmD, BCPS; MSHP President; CoxHealth, Springfield |
“Here comes the sun, and I say, it’s alright.”- The Beatles
“Spring is nature’s way of saying ‘Let’s party!’”- Robin Williams
“Where flowers bloom, so does hope.”- Lady Bird Johnson
Happy Spring!! What an amazing time of year (allergies and antihistamines aside)! As I write this, it’s been two years to the day since Missouri announced its first case of COVID-19. Spring is a time of new beginnings, and I am so ready for that to happen!
|
|
Board of Director's Update |
|
Board Update
By: Nathan Hanson, PharmD, MS, BCPS
January
- Planning for Legislative Day and Spring Meeting is taking place.
- The board voted to sponsor Midwest Pharmacy Resident’s Conference.
- The Missouri Board of Pharmacy Taskforce on Working Conditions has requested more information/recommendation on staffing levels from hospital pharmacists. An MSHP subgroup has been formed to develop recommendations to bring back to the MSHP Board prior to providing a recommendation to the BOP.
February
- Discussed Internal Audit, which will take place in March.
-
Legislative Day is April 6th.
- To increase technician participation, the board voted to make pharmacy technician registration free for the Spring Meeting.
- The board approved the proposed slate of candidates for 2022-2023 Board of Directors.
- Discussed the possibility to partner with ASHP for HRSA Grant Opportunity. MSHP has signed onto a grant which seeks to fund a community-based workforce to build Covid-19 vaccine confidence. Missouri has been designated as a high priority state. If the ASHP grant request is approved, MSHP will put together a team.
|
|
Finding Your Voice
By: Annie Kliewer, PharmD, BCPS
Legislative advocacy can be an intimidating endeavor. It requires that you know what bills have been introduced to the legislature and if they are important for your profession. Then, it is important to know what those pieces of legislation say and what this means for your profession. The bills up for discussion during the 2022 Missouri Legislative Session affect all of us. They affect our profession as pharmacists and the level of care that can be provided to our patients. The following are the pharmacy/healthcare related bills of MSHP, MHA and MPA’s advocacy focus for this 2022 Legislative session...
|
|
Research & Education Foundation Update: |
|
The MSHP R&E Foundation continues to offer our new Resident Ground Rounds series and our Preceptor Development Series.
Information for the Resident Ground Rounds Series can be found here:
|
|
Tony Huke, Pharm.D., BCPS
MSHP R&E Executive Director
|
|
Preceptor Development: How to Enhance Preceptor Skills to Ensure Student Success
By: Jordan Welch, Pharm.D. Candidate 2022, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Sara Lingow, Pharm.D., BCACP
What is a preceptor? Pharmacy preceptors are mentors and educators to pharmacy students and residents. They facilitate approximately 30% of the Doctor of Pharmacy curriculum for student pharmacists via practice-based learning.1
|
|
Nonsteroidal Mineralcorticoid Receptor Antagonists in Diabetic Kidney Disease
Author: Stephanie Chau PharmD and Sarah Billings PharmD, BCACP, CDCES
|
|
Program Number: 2022-02-03
Approval Dates: April 1, 2022 - October 1, 2022
Approved Contact Hours: 1 hour (1) CE per session
Learning Objectives
- Compare the difference between the nonsteroidal mineralcorticoid receptor antagonist finerenone to steroidal mineralocorticoid receptor antagonists
- Assess literature on cardiovascular and renal effects of finerenone in type 2 diabetics with diabetic kidney disease
- Review other medications with cardiovascular and renal benefits used in type 2 diabetics
|
|
Review of Calcitonin Gene-Related Peptide (CGRP) Inhibitors for Migraine Treatment
Authors: Lauren McCulley, PharmD, Center for Behavioral Medicine - Kansas City, MO And Mary Beth Dameron, PharmD, BCACP, University Health - Kansas City, MO
|
|
Program Number: 2022-02-02
Approval Dates: April 1, 2022 - October 1, 2022
Approved Contact Hours: 1 hour (1) CE per session
Learning Objectives
- Identify the pathophysiology for migraines
- Describe the role of CGRP inhibitors in migraine therapy
- Differentiate dosing and mechanism of action between the different CGRP inhibitors
- Analyze the relevant studies looking at the safety and efficacy of CGRP inhibitors in migraine treatment
- Determine the place in therapy for CGRP inhibitors
|
|
Tenecteplase Compared to Alteplase for Acute Ischemic Strokes
Authors: Avery Tolliver, PharmD; PGY1 Pharmacy Resident
Mentor: Blake Rosenfelder, PharmD; Clinical Pharmacy Specialist
Mercy Hospital, Springfield, MO
|
|
Program Number: 2022-04-07
Approval Dates: April 1, 2022 - October 1, 2022
Approved Contact Hours: 1 hour (1) CE per session
Learning Objectives
- Identify similarities and differences between tenecteplase and alteplase for fibrinolysis.
- Identify ischemic stroke patients in which tenecteplase could be of benefit.
- Discuss the most recent data surrounding the use of tenecteplase for ischemic strokes.
|
|
Featured Clinical Topic:
Opioid Use Disorder: Identification and Management in the Acute Setting
|
|
By Madeline Taylor, BS, PharmD 2022 Candidate, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Julianne Yeary, PharmD, BCCCP
|
|
Introduction
Opioid overdose deaths continue to increase in both urban and rural areas of Missouri, accounting for 1 out of every 56 deaths in 2018.1 The rise in patients suffering from opioid use disorder (OUD) is placing a great burden on the healthcare system. Establishing preventative measures and providing timely recognition and initiation of treatment for patients suffering from OUD is crucial.
|
|
Featured Clinical Topic:
Magnesium for the Treatment of Postoperative Pain
|
|
By: Brittany Bush, PharmD Candidate 2022, Xavier University of Louisiana College of Pharmacy
Mentor: Rachel C. Wolfe, PharmD, MHA, BCCCP, Barnes-Jewish Hospital – Saint Louis, Missouri
|
|
Acute postoperative pain often occurs after surgery with the most severe pain noted within the first 72 hours after intervention.1,2 Systemic opioids are routinely employed to manage postoperative pain. However, they can be associated with significant side effects, including long-term use and dependence.3-5
|
|
Featured Clinical Topic:
Lumateperone for Treatment of Schizophrenia
|
|
By: Hae Shim, PharmD Candidate 2022, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Danielle Moses, PharmD, BCPP, SSM Health DePaul Hospital
|
|
Schizophrenia
Schizophrenia is a chronic psychological disorder that affects 1% of the general population1 and is considered one of the top 15 leading causes of disability worldwide.2 Schizophrenia is characterized by having two symptoms present for a significant portion of one month (less if treated). Symptoms may include delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, negative symptoms. At least one presenting symptom must be a positive symptom of schizophrenia- delusions, hallucinations, or disorganized speech.3 Although the progression of schizophrenia may differ among individuals, it can affect the quality of life if not managed properly.4
|
|
Featured Clinical Topic:
Pandemic-Induced Anxiety Leads to Increased Cannabis Use in Pregnant Women
|
|
By: Brittany Heuay, PharmD Candidate 2022; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Kara Berges, PharmD; Mercy Pharmacy Wentzville
The COVID-19 pandemic has had far-reaching effects beyond the illness caused by the novel virus. The disruption and isolation brought on by the pandemic has increased the demand for mental health services as feelings of loneliness, loss, grief, and anxiety overwhelm those with and without pre-existing mental health illness1.
|
|
Featured Clinical Topic:
The Effects of Marijuana on Adolescent Development
|
|
By: Nicole Evans-Turk, Pharm.D Candidate 2022, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Amy Tiemeier, Pharm.D., BCPS
With the growing medicalization of marijuana and legalization of recreational marijuana, information on the medicinal value of the plant as well as risks of using marijuana are needed. With any drug, there are risks and benefits to its use. Marijuana is the most used drug by adolescents.1
|
|
Greater Kansas City Society of Health-System Pharmacists (GKCSHP)
Registrants for MSHP/KCHP Spring Meeting
Thursday April 28, 2022 from 4-6pm
Char Bar (4050 Pennsylvania Ave, Kansas City, MO 64111)
President: Kerra Cissne, PharmD, BCPS (kerra.cissne@gmail.com)
______________________________________________________________________
Mid-Missouri Society of Health-System Pharmacists (MMSHP)
President: Alexandria Stringberg, PharmD, BCPS (stringberga@health.missouri.edu)
_______________________________________________________________________
Saint Louis Society of Health-System Pharmacists (STLSHP)
MSHP/KCHP Spring Meeting Networking Happy Hour
Join us for a networking happy hour during the Virtual Spring Meeting Week to connect with MSHP & STLSHP members!
Thursday April 28, 2022 from 4-6 pm @ Louie's Wine Dive (16 S Bemiston Ave, Clayton, MO 63105)
STLSHP/GCCP Networking Happy Hour
Wednesday May 25, 2022 at 5pm
Sanctuaria (4198 Manchester Ave, St. Louis, 63110)
STLSHP Meeting
Join us for a dinner program discussing the use of rivaroxaban in peripheral artery disease.
Thursday June 16, 2022
Time and Location TBD
STLSHP is currently seeking nominations for the position of President-elect! The president-elect position is a three-year term (July-June), serving as president-elect, president, and past-president. If you or someone you know is interested in one of these positions, please contact Gabrielle Gibson (gabrielle.gibson@bjc.org) by April 30th.
If you are interested in becoming more involved in STLSHP, one of our committees might be right for you! The Membership committee helps to coordinate membership events and the Newsletter committee reviews and coordinates our local STLSHP newsletter (we are bringing it back 😊). Please contact Yvonne Burnett (Yvonne.burnett@uhsp.edu) if you are interested in becoming a member.
President: Yvonne Burnett, Pharm.D., BCIDP (Yvonne.Burnett@uhsp.edu)
_______________________________________________________________________
Southeast Missouri Society of Health-System Pharmacists (SEMSHP)
President: Janice Wesbecher (jbueter@sehealth.org)
|
|
Upcoming Featured Clinical Topics:
- May/Jun 2022: FULL Critical Care/Pulmonary/Emergency Medicine
- July/August 2022: Cardiology/Anticoagulation
- Sept/Oct 2022: Special Populations (Geriatrics, Pediatrics, Women’s/Men’s Health)/Transitions of Care
- Nov/Dec 2022: ID/Vaccines
|
|
Newsletter Submission Deadlines:
- May/Jun 2022: Due April 25
- July/August 2022: Due June 27
- Sept/Oct 2022: Due August 22
- Nov/Dec 2022: Due October 24
|
|
Newsletter Submission Guidelines
- Pharmacists, pharmacy technicians, and pharmacy students in Missouri are eligible to submit content for publication in the MSHP Newsletter. Student submissions need to include pharmacist oversight.
- Submit content to the current Newsletter Committee Chair on or before the established deadlines.
- CE and Featured Clinical Topics must be approved by the Newsletter Committee Chair in advance of article submission, to prevent duplicates. Duplicate articles submitted without advanced approval may not be published.
- Recommended length of submissions for committee, affiliate, college/schools of pharmacy, and student chapter reports is half to one page in length.
- Recommended length of submissions for featured clinical topics is 1 to 2 pages, without references.
- Recommended length of CE articles is individualized, based on the amount of CE provided.
- Recommended length of submission for other categories is 1 to 2 pages.
|
|
MSHP Board of Directors & Committee Chairs |
|
2021-2022 Board Members
President:
President-Elect:
Immediate Past President:
|
|
2021-2022 Committee Chairs
Vendor Relations Board Liaison:
Membership Committee:
Public Policy Committee:
Newsletter Committee:
Education and Programming:
Website & Social Media:
|
|
If you have any questions, comments, or wish to submit an article to for MSHP Newsletter, please contact the Newsletter Committee Chair (Laura Challen) or another Newsletter Committee member.
2021-2022 MSHP Newsletter Committee Members
|
|
|
|
|
|
|
